Calliditas Therapeutics (CALT) PT Raised to $62 at H.C. Wainwright
Tweet Send to a Friend
H.C. Wainwright analyst Edwin Zhang raised the price target on Calliditas Therapeutics (NASDAQ: CALT) to $62.00 (from $52.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
